| Evaluation of chemoprevention of oral cancer with Spirulina fusiformis 1995 · Spirulina fusiformis · Pan tobacco chewers in Kerala, India, with oral leukoplakia; age and sex not reported | 1 g | 1 year | 44 |
| Spirulina platensis versus silymarin in the treatment of chronic hepatitis C virus infection. A pilot randomized, comparative clinical trial 2012 · Spirulina treated Group · Males and females aged 18–70 with chronic hepatitis C genotype 4; interferon-naive patients, relapsers or non-responders | 1.5 g | 26 weeks | 30 |
| The effects of spirulina (Arthrospira platensis) supplementation on anthropometric indices, blood pressure, sleep quality, mental health, fatigue status and quality of life in patients with ulcerative colitis: A randomised, double-blinded, placebo-controlled trial 2021 · spirulina · People with ulcerative colitis; age range and sex not specified | 1 g | 8 weeks | 40 |
| The Effects of Spirulina maxima Extract on Memory Improvement in Those with Mild Cognitive Impairment: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial 2022 · SM70EE group · Adults aged 60 years or older with mild cognitive impairment | 1 g | 12 weeks | 40 |
| Efficacy of Spirulina 500 mg vs Triamcinolone Acetonide 0.1% for the Treatment of Oral Lichen Planus: A Randomized Clinical Trial 2022 · group A · People with histopathologically confirmed oral lichen planus and burning sensation; age and sex not reported | 1 g | 8 weeks | 30 |
| The effects of spirulina intake on clinical and metabolic parameters in Alzheimer's disease: A randomized, double-blind, controlled trial 2023 · spirulina group · Patients with Alzheimer's disease; age and sex not stated | 500 mg | 12 weeks | 30 |
| The effects of Spirulina Platensis on anthropometric indices, appetite, lipid profile and serum vascular endothelial growth factor (VEGF) in obese individuals: a randomized double blinded placebo controlled trial 2017 · Spirulina platensis group · Obese adults aged 20–50 years | 1 g | 12 weeks | 29 |
| Effect of high-dose Spirulina supplementation on hospitalized adults with COVID-19: a randomized controlled trial 2024 · Spirulina group (non-ICU and ICU) · Adults aged 18 years or older hospitalized with confirmed COVID-19 and oxygen saturation ≤94%, including ICU and non-ICU patients | 15.2 g | 6 days | 91 |
| Clinical comparison of the efficacy of spirulina platensis and cetirizine for treatment of allergic rhinitis 2020 · experimental (spirulina) group · People aged 8–58 with persistent allergic rhinitis | 2 g | 60 days | 26 |
| Spirulina Platensis Attenuates Rebound Dyspeptic Symptoms After Proton Pump Inhibitors' Discontinuation: Phase 2 Placebo-controlled Trial 2024 · Spirulina · Brazilian patients who regularly used proton pump inhibitors and were eligible to discontinue them after clinical and endoscopic evaluation | 1.6 g | 60 days | 18 |
| Effects of spirulina consumption on body weight, blood pressure, and endothelial function in overweight hypertensive Caucasians: a double-blind, placebo-controlled, randomized trial 2016 · spirulina group · overweight Caucasian adults with hypertension and no evidence of cardiovascular disease | 2 g | 90 days | — |
| Spirulina platensis effectively ameliorates anthropometric measurements and obesity-related metabolic disorders in obese or overweight healthy individuals: A randomized controlled trial 2018 · SP · Overweight or obese healthy individuals; age and sex not reported | 2 g | 12 weeks | — |
| Multiple micronutrient supplementation using spirulina platensis and infant growth, morbidity, and motor development: Evidence from a randomized trial in Zambia 2019 · SP group · Infants aged 6–18 months in Zambia, in a setting with high rates of stunting and underweight | 10 g | 1 year | 250 |
| Multiple micronutrient supplementation using spirulina platensis and infant growth, morbidity, and motor development: Evidence from a randomized trial in Zambia 2019 · SP group · Infants aged 6–18 months in Zambia, in a setting with high rates of stunting and underweight | 10 g | 1 year | 250 |
| Nutrition rehabilitation of undernourished children utilizing Spiruline and Misola 2006 · B: Spiruline plus traditional meals · Undernourished children aged 6–60 months; median age 15.29 months; both sexes | 10 g | 8 weeks | 170 |
| Nutrition rehabilitation of undernourished children utilizing Spiruline and Misola 2006 · C: Spiruline plus Misola · Undernourished children aged 6–60 months; median age 15.29 months; both sexes | 10 g | 8 weeks | 170 |
| Effect of Arthrospira (Spirulina) maxima Supplementation and a Systematic Physical Exercise Program on the Body Composition and Cardiorespiratory Fitness of Overweight or Obese Subjects: A Double-Blind, Randomized, and Crossover Controlled Trial 2018 · SE (systematic exercise with Spirulina maxima) · Sedentary male adults with BMI over 25 kg/m², overweight or obese | 4.5 g | 12 weeks | 28 |
| Effect of Arthrospira (Spirulina) maxima Supplementation and a Systematic Physical Exercise Program on the Body Composition and Cardiorespiratory Fitness of Overweight or Obese Subjects: A Double-Blind, Randomized, and Crossover Controlled Trial 2018 · Sm (Spirulina maxima without systematic exercise) · Sedentary male adults with BMI over 25 kg/m², overweight or obese | 4.5 g | 12 weeks | 24 |
| The effect of Spirulina platensis versus soybean on insulin resistance in HIV-infected patients: a randomized pilot study 2011 · spirulina group · Adults with HIV infection receiving or eligible for HAART who were classified as insulin resistant | 19 g | 8 weeks | 17 |
| Spirulina supplementation improves oxygen uptake in arm cycling exercise 2020 · Spirulina · Healthy males, mean age 21 years, unfamiliar with arm cycling exercise | 6 g | 7 days | 11 |
| Ergogenic and antioxidant effects of spirulina supplementation in humans 2010 · spirulina · Moderately trained adult males | 6 g | 4 weeks | 9 |
| Antihypertensive and antihyperlipemic of spirulina (Arthrospira platensis) sauce on patients with hypertension: A randomized triple-blind placebo-controlled clinical trial 2021 · Spirulina-fortified dressing · Patients with hypertension; age and sex not specified | 2 g | 8 weeks | — |
| A randomized, double-blind placebo-controlled add-on trial to assess the efficacy, safety, and anti-atherogenic effect of spirulina platensis in patients with inadequately controlled type 2 diabetes mellitus 2023 · S. platensis group · Patients with type 2 diabetes mellitus inadequately controlled on metformin | 2 g | 90 days | — |
| Benefits of Dietary Supplementation with Specific Silicon-Enriched Spirulina on Arterial Function in Healthy Elderly Individuals: A Randomized, Placebo-Controlled Trial 2025 · silicon-enriched spirulina (SpSi) · Healthy men and women aged 60–75 years without pre-existing chronic illness or cardiovascular events | 3.5 g | 180 days | 60 |
| Efficacy of spirulina extract plus zinc in patients of chronic arsenic poisoning: a randomized placebo-controlled study 2006 · spirulina extract plus zinc · Patients with chronic arsenic poisoning | 500 mg | 16 weeks | 24 |
| Spirulina maxima Decreases Endothelial Damage and Oxidative Stress Indicators in Patients with Systemic Arterial Hypertension: Results from Exploratory Controlled Clinical Trial 2018 · Spirulina maxima group · Adults older than 18 years with stage 1–2 systemic arterial hypertension receiving stable ACE-inhibitor treatment | 4.5 g | 12 weeks | 8 |
| The effects of spirulina supplementation on serum iron and ferritin, anemia parameters, and fecal occult blood in adults with ulcerative colitis: A randomized, double-blinded, placebo-controlled trial 2023 · spirulina · Adults with ulcerative colitis | 1 g | 8 weeks | 40 |
| Effects of Spirulina supplementation in patients with ulcerative colitis: a double-blind, placebo-controlled randomized trial 2024 · SP supplementation group · Adults aged 18–65, female and male, with clinically diagnosed active mild-to-moderate ulcerative colitis | 1 g | 8 weeks | 40 |
| Effects of spirulina (Arthrospira) platensis supplementation on inflammation, physical and mental quality of life, and anthropometric measures in patients with relapsing-remitting multiple sclerosis (RRMS): a triple-blinded, randomized, placebo-controlled trial 2025 · Spirulina group · Adults aged 18–50 with relapsing-remitting multiple sclerosis (RRMS), BMI 18.5–30 kg/m² and EDSS 0–6, on stable disease-modifying therapy | 1 g | 12 weeks | 40 |
| The Combinatory Effect of Spirulina Supplementation and Resistance Exercise on Plasma Contents of Adipolin, Apelin, Ghrelin, and Glucose in Overweight and Obese Men 2022 · T+S · Overweight and obese men; ages not reported; no stated disease | 1 g | 8 weeks | 15 |
| The Combinatory Effect of Spirulina Supplementation and Resistance Exercise on Plasma Contents of Adipolin, Apelin, Ghrelin, and Glucose in Overweight and Obese Men 2022 · S · Overweight and obese men; ages not reported; no stated disease | 1 g | 8 weeks | 15 |
| Spirulina supplementation and circuit resistance training (CRT) reduce serum asprosin and appetite and improve energy balance in men with obesity and overweight 2025 · training plus spirulina · Men with obesity or overweight (BMI > 25) | 1 g | 8 weeks | 15 |
| Spirulina supplementation and circuit resistance training (CRT) reduce serum asprosin and appetite and improve energy balance in men with obesity and overweight 2025 · spirulina · Men with obesity or overweight (BMI > 25) | 1 g | 8 weeks | 15 |
| Hypocholesterolemic effect of spirulina in patients with hyperlipidemic nephrotic syndrome 2002 · Group II (medication plus Spirulina) · Children aged 2 to 13 years with nephrotic syndrome and hyperlipidemia | 1 g | 60 days | — |
| The Effect of Eight Weeks of Aerobic Exercise and Spirulina Supplementation on Some Liver Enzymes, Body Composition, and Cardiorespiratory Fitness in Overweight and Obese Adult Women 2025 · spirulina with aerobic exercise · Overweight and obese women aged 25–40 years | 1 g | 8 weeks | — |
| The Effect of Eight Weeks of Aerobic Exercise and Spirulina Supplementation on Some Liver Enzymes, Body Composition, and Cardiorespiratory Fitness in Overweight and Obese Adult Women 2025 · spirulina-only · Overweight and obese women aged 25–40 years | 1 g | 8 weeks | — |
| Effect of Spirulina maxima Supplementation on Calcium, Magnesium, Iron, and Zinc Status in Obese Patients with Treated Hypertension 2016 · Spirulina group · Adults aged 25–60 with obesity and well-controlled hypertension receiving stable antihypertensive treatment | 2 g | 90 days | 25 |
| Effects on Spirulina Supplementation on Immune Cells' Parameters of Elite College Athletes 2022 · spirulina supplementation group (SP) · Elite college soccer players; age and sex are not specified. Female players were not studied. | 1.5 g | 8 weeks | 20 |
| An attempt to induce an immunomodulatory effect in rowers with spirulina extract 2018 · supplemented group · Men aged about 20 years who were members of the Polish Rowing Team and undertaking strenuous training | 1.5 g | 6 weeks | 10 |
| Spirulina maxima improves insulin sensitivity, lipid profile, and total antioxidant status in obese patients with well-treated hypertension: a randomized double-blind placebo-controlled study 2017 · Spirulina group · Obese patients with treated hypertension | 2 g | 90 days | — |
| Arthrospira Enhances Seroclearance in Patients with Chronic Hepatitis B Receiving Nucleos(t)ide Analogue through Modulation of TNF-α/IFN-γ Profile 2022 · low-dose group · Men and women aged 20–75 with chronic hepatitis B, treated with nucleos(t)ide analogues for at least one year and undetectable HBV DNA | 3 g | 26 weeks | 20 |
| Arthrospira Enhances Seroclearance in Patients with Chronic Hepatitis B Receiving Nucleos(t)ide Analogue through Modulation of TNF-α/IFN-γ Profile 2022 · standard-dose group · Men and women aged 20–75 with chronic hepatitis B, treated with nucleos(t)ide analogues for at least one year and undetectable HBV DNA | 6 g | 26 weeks | 20 |
| Effects of Spirulina platensis supplementation on lipid profile in HIV-infected antiretroviral naïve patients in Yaounde-Cameroon: a randomized trial study 2014 · intervention group (Spirulina group) · Adults aged 18–65 with HIV infection, antiretroviral-naïve, and CD4 count ≥400 cells/μL | 10 g | 26 weeks | 82 |
| Ingestion of a variety of non-animal-derived dietary protein sources results in diverse postprandial plasma amino acid responses which differ between young and older adults 2024 · SPIR (spirulina) · Healthy young adults aged 22 ± 1 years and healthy older adults aged 69 ± 2 years; both sexes | 30 g | 1 day | 22 |
| Antioxidant Efficacy of a Spirulina Liquid Extract on Oxidative Stress Status and Metabolic Disturbances in Subjects with Metabolic Syndrome 2022 · Spirulysat® group · Adults aged 18–65 with metabolic syndrome | 20 mL | 12 weeks | 20 |
| Fourteen-Days Spirulina Supplementation Increases Hemoglobin, but Does Not Provide Ergogenic Benefit in Recreationally Active Cyclists: A Double-Blinded Randomized Crossover Trial 2024 · spirulina · Recreationally active adults; 14 male and 3 female, mean age 23 ± 5 years | 6 g | 2 weeks | 17 |
| Clinical Safety of a High Dose of Phycocyanin-Enriched Aqueous Extract from Arthrospira (Spirulina) platensis: Results from a Randomized, Double-Blind, Placebo-Controlled Study with a Focus on Anticoagulant Activity and Platelet Activation 2016 · Cyactiv (aqueous cyanophyta extract, ACE) · Adults aged 25–65 with chronic pain related to specific joints for more than 6 months | 2.3 g | 2 weeks | 12 |
| Algae Ingestion Increases Resting and Exercised Myofibrillar Protein Synthesis Rates to a Similar Extent as Mycoprotein in Young Adults 2023 · SPIR (spirulina) · Healthy young adults, age 22 ± 3 years; 18 male and 18 female across all arms | 25 g | 1 day | 12 |
| Impact of a 12-week High-Intensity Interval Training With Spirulina Supplementation on Insulin Resistance-Mediated by Apo-A, -B, and -J in Men With Obesity HIIT With Spirulina on Apolipoproteins 2025 · spirulina group (SG) · Men aged 25–40 with obesity (BMI >30 kg/m²), without specified illness | 6 g | 12 weeks | 11 |
| Impact of a 12-week High-Intensity Interval Training With Spirulina Supplementation on Insulin Resistance-Mediated by Apo-A, -B, and -J in Men With Obesity HIIT With Spirulina on Apolipoproteins 2025 · SG + HIIT group · Men aged 25–40 with obesity (BMI >30 kg/m²), without specified illness | 6 g | 12 weeks | 11 |
| Spirulina supplementation prevents exercise-induced lipid peroxidation, inflammation and skeletal muscle damage in elite rugby players 2022 · spirulina (SPI) · Elite male rugby players; ages and health conditions not stated | 5.7 g | 7 weeks | 9 |
| A randomized double-blind, placebo-controlled study to establish the effects of spirulina in elderly Koreans 2008 · spirulina · Healthy adults aged 60–87 years | 8 g | 16 weeks | — |
| Hypolipidemic Effect of Arthrospira (Spirulina) maxima Supplementation and a Systematic Physical Exercise Program in Overweight and Obese Men: A Double-Blind, Randomized, and Crossover Controlled Trial 2019 · SE (systematic exercise with Spirulina maxima supplementation) · Sedentary men aged 26 ± 5 years with overweight or obesity (BMI ≥25 kg/m²); some had dyslipidemia | 4.5 g | 6 weeks | — |
| Hypolipidemic Effect of Arthrospira (Spirulina) maxima Supplementation and a Systematic Physical Exercise Program in Overweight and Obese Men: A Double-Blind, Randomized, and Crossover Controlled Trial 2019 · Sm (Spirulina maxima supplementation without systematic exercise) · Sedentary men aged 26 ± 5 years with overweight or obesity (BMI ≥25 kg/m²); some had dyslipidemia | 4.5 g | 6 weeks | — |
| Possible ameliorative role of Spirulina platensis on coagulation factors, lymphocytopenia, and malnutrition in ICU patients with COVID-19 2023 · Spirulina (Sp) group · Adults aged 48–66 hospitalized in the ICU with COVID-19 | 5 g | 2 weeks | — |